Opportunity Information: Apply for RFA CA 09 009

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Physical Science Oncology Centers (U54)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.399 Cancer Control.
  • This funding opportunity was created on Dec 9, 2008 and posted on Dec 9, 2008.
  • Applicants must submit their applications by Mar 13, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $2,250,000.00 in funding.
  • Eligible applicants include: State governments City or township governments County governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses For profit organizations other than small businesses Private institutions of higher education Public and State controlled institutions of higher education.
  • Other Eligible Applicants include the following Eligible Agencies of the Federal Government Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations U.S. Territory or Possession.
Apply for RFA CA 09 009

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Physical Science Oncology Centers (U54) opportunity (Funding Opportunity Number RFA-CA-09-009) is a National Cancer Institute (NCI), NIH cooperative agreement designed to create a coordinated network of research centers that merge physical sciences with cancer biology. The central idea is that cancer is not only a genetic or biochemical disease, but also a process shaped by physical laws across many scales, from molecules and cells to tissues and whole tumors. Through this program, NCI sought applications that would build a collaborative “Network of Physical Science Oncology Centers (PS-OCs)” aimed at advancing a more complete, physics-informed understanding of how cancer emerges, evolves, and behaves.

At the heart of the initiative is team science that intentionally crosses traditional discipline boundaries. The PS-OCs were expected to bring together experts in physics, cancer biology, physical chemistry, mathematics, and engineering, and to assemble the infrastructure and shared capabilities needed for genuinely integrated work. Rather than funding isolated projects, the program emphasizes centers that can support coordinated research programs and participate in network-wide collaboration, with the expectation that insights and tools developed in one center can be tested, refined, and extended through iterative interactions with other centers in the network.

The FOA highlights three major research thrusts that define what these centers are meant to do. First, centers should originate and test novel, non-traditional physical science-based approaches to understanding and controlling cancer, meaning ideas and methods that might not normally be considered part of mainstream cancer research. Second, they should generate “orthogonal” physical measurements and integrate them with existing cancer knowledge; in practice, this implies collecting fundamentally different kinds of quantitative data (for example, force, stiffness, transport, spatial organization, dynamics, and other measurable physical properties) and combining those measurements with biological and clinical understanding. Third, they should develop and evaluate theory-driven approaches rooted in physics, with the goal of producing a comprehensive and dynamic picture of cancer processes rather than a static snapshot. Taken together, the program is oriented toward building predictive, mechanistic understanding by combining experimentation, measurement, modeling, and theory.

The long-term outcome NCI was aiming for is more than incremental progress on existing questions. The announcement frames the initiative as a catalyst for new bodies of knowledge and potentially new fields of cancer study, specifically those that define which aspects of physics, chemistry, and engineering are critical at different levels of cancer biology. In other words, the PS-OC network was intended to reshape how certain cancer problems are conceptualized, measured, and modeled, and to encourage the field to adopt frameworks that can capture tumor behavior as a complex, multiscale physical-biological system.

Administratively, this opportunity used the U54 cooperative agreement mechanism, which typically means substantial programmatic involvement by NIH staff compared with a standard research project grant. The opportunity was categorized as discretionary funding, with activity categories listed under education and health, and associated CFDA numbers 93.393 (Cancer Cause and Prevention Research) and 93.399 (Cancer Control). The posted and creation date was December 9, 2008, with an original and current closing date of March 13, 2009, and an archive date of April 13, 2009. The listed award ceiling was $2,250,000, and there was no cost sharing or matching requirement stated.

Eligibility was broad and included many organization types: public and private institutions of higher education, nonprofits (including both 501(c)(3) and certain non-501(c)(3) nonprofits), small businesses, and for-profit organizations (including those other than small businesses). Government entities at the state, county, and city/township levels were also eligible. The FOA additionally allowed other eligible applicants such as eligible federal agencies, U.S. territories or possessions, regional organizations, and non-U.S. entities (foreign organizations), reflecting the network-building intent and the desire to recruit the best teams and capabilities regardless of sector, and in some cases geography, as permitted by NIH policy and the FOA’s specifics.

Overall, the Physical Science Oncology Centers (U54) FOA was a center-based, network-focused funding opportunity meant to accelerate cancer research by embedding physical science thinking, measurement, and theory into the study of cancer. The expectation was that by building shared infrastructure, forming deeply integrated multidisciplinary teams, and coordinating across a national (and potentially international) network, these centers would produce new quantitative insights and conceptual frameworks that conventional approaches might miss, ultimately improving how cancer is understood and, in the longer run, how it can be controlled.

FAQs: Physical Science Oncology Centers (U54) - RFA-CA-09-009

What is the Physical Science Oncology Centers (U54) opportunity?

The Physical Science Oncology Centers (U54) opportunity (Funding Opportunity Number RFA-CA-09-009) is a National Cancer Institute (NCI), NIH cooperative agreement intended to create a coordinated network of research centers that merge physical sciences with cancer biology. The program is built around the idea that cancer is shaped not only by genetics and biochemistry, but also by physical laws operating across scales, from molecules and cells to tissues and whole tumors.

What was NCI trying to accomplish with this program?

NCI aimed to build a collaborative “Network of Physical Science Oncology Centers (PS-OCs)” to advance a more complete, physics-informed understanding of how cancer emerges, evolves, and behaves. The intent was to accelerate cancer research by embedding physical science thinking, measurement, and theory into cancer studies, and to encourage new quantitative and conceptual frameworks that conventional approaches might miss.

What does PS-OC stand for?

PS-OC refers to the “Physical Science Oncology Center,” and the broader program intended to create a “Network of Physical Science Oncology Centers (PS-OCs)” operating as a coordinated set of centers rather than isolated projects.

Is this a single-project grant or a center-based program?

This was a center-based program. The FOA emphasized building research centers that can support coordinated research programs, shared capabilities, and network-wide collaboration, rather than funding standalone, disconnected projects.

What is the U54 mechanism, and what does “cooperative agreement” imply?

The opportunity used the U54 cooperative agreement mechanism. As described in the provided information, this typically involves substantial programmatic involvement by NIH staff compared with a standard research project grant, reflecting the networked and coordinated nature of the initiative.

What types of disciplines were expected to be involved?

The PS-OCs were expected to intentionally cross traditional discipline boundaries by bringing together experts in physics, cancer biology, physical chemistry, mathematics, and engineering, along with the infrastructure needed for truly integrated work across these areas.

What is meant by “team science” in this FOA?

In this context, “team science” refers to intentionally integrated, multidisciplinary work where physical scientists and cancer researchers collaborate closely. The goal is to merge methods, measurements, modeling, and theory so the resulting work is genuinely integrated rather than parallel efforts housed under one umbrella.

Why does the FOA emphasize a “network” of centers?

The network emphasis was meant to ensure that insights and tools developed in one center could be tested, refined, and extended through iterative interactions with other centers. The FOA envisioned coordinated research across centers, with shared learning and collaboration at the network level.

What were the major research thrusts highlighted in the FOA?

The FOA described three major research thrusts for PS-OCs: (1) originating and testing novel, non-traditional physical science-based approaches to understanding and controlling cancer; (2) generating “orthogonal” physical measurements and integrating them with existing cancer knowledge; and (3) developing and evaluating theory-driven approaches rooted in physics to build comprehensive, dynamic pictures of cancer processes.

What does “non-traditional physical science-based approaches” mean here?

Based on the FOA description, this refers to ideas and methods grounded in the physical sciences that would not typically be considered part of mainstream cancer research, with an emphasis on originating and testing new approaches for understanding and potentially controlling cancer.

What are “orthogonal” physical measurements in the context of this program?

“Orthogonal” measurements are fundamentally different kinds of quantitative physical data that complement traditional biological and clinical information. The FOA examples include measures such as force, stiffness, transport, spatial organization, and dynamics, as well as other measurable physical properties, integrated with cancer knowledge.

What does the FOA mean by “theory-driven approaches rooted in physics”?

The FOA called for developing and evaluating approaches that use physics-based theory and modeling to explain cancer processes. The goal was to move toward a comprehensive and dynamic understanding (how cancer changes and behaves over time and across scales) rather than relying on static snapshots.

What kinds of outcomes was NCI aiming for long-term?

The intended long-term outcome went beyond incremental advances on existing questions. The initiative was framed as a catalyst for new bodies of knowledge and potentially new fields of cancer study, specifically identifying which aspects of physics, chemistry, and engineering are critical at different levels of cancer biology.

How does the FOA conceptualize cancer?

The FOA treats cancer as more than a genetic or biochemical disease. It describes cancer as a process shaped by physical laws across many scales, from molecules and cells to tissues and whole tumors, and seeks approaches that reflect cancer as a complex, multiscale physical-biological system.

What activity categories were associated with this opportunity?

The opportunity was categorized as discretionary funding, with activity categories listed under education and health.

What CFDA numbers were associated with this opportunity?

The provided information lists two associated CFDA numbers: 93.393 (Cancer Cause and Prevention Research) and 93.399 (Cancer Control).

What was the award ceiling?

The listed award ceiling was $2,250,000.

Was cost sharing or matching required?

No cost sharing or matching requirement was stated in the provided information.

Who was the sponsoring agency?

The sponsoring organization was the National Cancer Institute (NCI) within the National Institutes of Health (NIH).

What organizations were eligible to apply?

Eligibility was broad and included: public and private institutions of higher education; nonprofits (including both 501(c)(3) and certain non-501(c)(3) nonprofits); small businesses; for-profit organizations (including those other than small businesses); and government entities at the state, county, and city/township levels.

Were non-U.S. (foreign) organizations eligible?

Yes. The FOA allowed non-U.S. entities (foreign organizations) among other eligible applicants, consistent with the network-building intent and the desire to recruit strong teams and capabilities, as permitted by NIH policy and the FOA specifics.

Were U.S. territories or possessions mentioned as eligible?

Yes. The FOA listed U.S. territories or possessions as among the other eligible applicants.

Were eligible federal agencies included?

Yes. The FOA allowed other eligible applicants such as eligible federal agencies.

Were regional organizations included as eligible applicants?

Yes. Regional organizations were included among other eligible applicants.

What were the key dates for this funding opportunity?

The posted and creation date was December 9, 2008. The original and current closing date was March 13, 2009. The archive date was April 13, 2009.

Is this funding opportunity still open?

No. The provided information indicates the closing date was March 13, 2009, and the opportunity was archived on April 13, 2009.

What was the overarching approach to research encouraged by the FOA?

The FOA encouraged an approach that combines experimentation, quantitative measurement of physical properties, modeling, and theory to build predictive, mechanistic understanding of cancer across scales, supported by shared center infrastructure and network collaboration.

Why did the FOA prioritize shared infrastructure and capabilities?

The program expected centers to assemble infrastructure and shared capabilities needed for integrated work across disciplines. This structure supports coordinated research programs within each center and helps the broader network share, test, and extend tools and insights across sites.

What does “predictive, mechanistic understanding” imply in the FOA framing?

In the FOA framing, it implies moving toward explanations and models that can account for how cancer processes work and change over time (mechanistic), and that can help anticipate behaviors or outcomes based on physical and biological principles (predictive), rather than simply describing observations.

How was the PS-OC network expected to influence the broader cancer research field?

The network was intended to reshape how certain cancer problems are conceptualized, measured, and modeled by encouraging frameworks that reflect tumor behavior as a complex, multiscale physical-biological system and by helping establish which physical science concepts matter at different levels of cancer biology.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: OVC FY 09 Intensive Case Management for Family Members of Homicide Victims in Rural Areas

Previous opportunity: Researching Implementation and Change while Improving Quality (R18)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 09 009

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 09 009) also looked into and applied for these:

Funding Opportunity
NINR Mentored Research Scientist Development Award for Underrepresented or Disadvantaged Investigators (K01) Apply for PAR 05 135

Funding Number: PAR 05 135
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $20,000
NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 08 047

Funding Number: PAR 08 047
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NINR Career Transition Award (K22) Apply for PAR 08 148

Funding Number: PAR 08 148
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Research on the Cognitive Sequelae of Parkinsons Disease (R01) Apply for PA 09 033

Funding Number: PA 09 033
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Established Investigator Award in Cancer Prevention and Control Apply for PAR 05 145

Funding Number: PAR 05 145
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Mentored Career Development Award to Promote Diversity (K01) Apply for PAR 06 220

Funding Number: PAR 06 220
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NCI Mentored Clinical Scientist Award to Promote Diversity (K08) Apply for PAR 06 221

Funding Number: PAR 06 221
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mentored Patient Oriented Research Award to Promote Diversity (K23) Apply for PAR 06 222

Funding Number: PAR 06 222
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Building Translational Research in Integrative Behavioral Science (R24) Apply for PAR 06 357

Funding Number: PAR 06 357
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $225,000
Cancer Prevention, Control, Behavioral, and Population Sciences Career Development Award (K07) Apply for PAR 06 381

Funding Number: PAR 06 381
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $105,000
Paul Calabresi Career Development Award For Clinical Oncology (K12) Apply for PAR 06 449

Funding Number: PAR 06 449
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The NCI Transition Career Development Award (K22) Apply for PAR 06 455

Funding Number: PAR 06 455
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $125,000
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (F31) Apply for PA 07 002

Funding Number: PA 07 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Feasibility Studies for Collaborative Interaction for Minority Institution/Cancer Center Partnership (P20) Apply for PAR 07 230

Funding Number: PAR 07 230
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 07 346

Funding Number: PAR 07 346
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
AIDS International Training and Research Program (D43) Apply for PAR 07 348

Funding Number: PAR 07 348
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
2009 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 09 011

Funding Number: RFA DA 09 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Pre Application for the 2009 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 09 044

Funding Number: PAR 09 044
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Innovative and Applied Emerging Technologies in Biospecimen Science (R21) Apply for RFA CA 09 004

Funding Number: RFA CA 09 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $275,000
Innovative and Applied Emerging Technologies in Biospecimen Science (R33) Apply for RFA CA 09 005

Funding Number: RFA CA 09 005
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 09 009", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.